Global engagement

Global engagement

Global engagement: Promoting innovative and inclusive approaches to research

An essential part of TDR’s work is to engage with the global health community to promote and facilitate the role of research for development and to advocate for the use of high-quality evidence to inform policy. TDR is at the interface between research and health care delivery and is embedded within the UN family through its cosponsors (UNICEF, UNDP, the World Bank, and WHO). This unique positioning allows TDR to create a bridge from local communities to the World Health Assembly to enable the broadest possible scope of dialogue and debate across the spectrum of health research – from priority setting to evidence-based policy-making at local, national, regional and global levels.

This global engagement includes promoting a broad range of community-based social innovations that are transforming health care delivery, shaping the research agenda, supporting the translation of evidence to policy, and leveraging a global network of more than 7000 scientists and experts who have been associated with TDR.
   

Recent news

Publications

Global action plan on antimicrobial resistance

Overview

At the Sixty-eight World Health Assembly in May 2015, the World Health Assembly endorsed a global action plan to tackle antimicrobial resistance, including antibiotic resistance, the most urgent drug resistance trend.

Antimicrobial resistance is occurring everywhere in the world, compromising our ability to treat infectious diseases, as well as undermining many other advances in health and medicine. The goal of the draft global action plan is to ensure, for as long as possible, continuity of successful treatment and prevention of infectious diseases with effective and safe medicines that are quality-assured, used in a responsible way, and accessible to all who need them.

To achieve this goal, the global action plan sets out five strategic objectives:

  • to improve awareness and understanding of antimicrobial resistance;
  • to strengthen knowledge through surveillance and research;
  • to reduce the incidence of infection;
  • to optimize the use of antimicrobial agents; and
  • develop the economic case for sustainable investment that takes account of the needs of all countries, and increase investment in new medicines, diagnostic tools, vaccines and other interventions.

 

WHO Team
National Action Plans and Monitoring and Evaluation, Surveillance, Prevention and Control
Number of pages
28
Reference numbers
ISBN: 9789241509763